HIV inhibitors are an important part of antiretroviral therapy used to control HIV infection. These medicines work by interfering with specific stages of the HIV replication process, helping reduce the amount of virus in the body. Different inhibitor classes target different viral enzymes.
HIV inhibitors are medicines designed to interfere with specific steps that HIV needs to reproduce. Because HIV can replicate rapidly and develop resistance when treatment is incomplete or ineffective, antiretroviral therapy generally combines medicines that act on different stages of the viral life cycle. The selection of treatment depends on factors such as the person's medical history, other medicines, resistance information, and clinical guidance.
HIV enters certain immune cells and uses their biological machinery to produce new copies of itself. Several viral enzymes and proteins are essential during this process. HIV inhibitors target these components or prevent particular stages of viral replication.
Common inhibitor categories include:
Each class acts at a different point in the HIV life cycle. This allows combinations of medicines to inhibit viral replication through multiple mechanisms.
Antiretroviral therapy uses combinations of medicines to suppress HIV replication. Modern treatment regimens commonly include drugs from different classes or medicines that combine multiple antiretroviral activities in a single formulation. The objective is sustained viral suppression rather than eliminating HIV from the body.
Important aspects of antiretroviral therapy include:
Treatment choices can change as new medicines become available or when resistance, drug interactions, side effects, or other clinical considerations require a different regimen.
HIV treatment is individualized because people can have different medical circumstances and treatment histories. Resistance testing may provide useful information when selecting or modifying therapy, particularly when treatment failure is suspected.
Healthcare professionals may consider previous antiretroviral exposure, other health conditions, potential drug interactions, pregnancy status where relevant, and laboratory results. Taking medicines as prescribed is also an important component of maintaining viral suppression.
HIV inhibitors therefore represent a central part of modern antiretroviral treatment. By targeting different stages of HIV replication, these medicines help prevent the virus from producing new copies and support sustained viral suppression. Continued medical monitoring helps healthcare professionals determine whether a treatment regimen remains appropriate and whether adjustments are needed over time.